Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Borkow

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Biochemistry|June 4, 1998
Physicochemical and biochemical properties of 2',5'-linked RNA and 2',5'-RNA:3',5'-RNA "hybrid" duplexesM Wasner, D Arion, G Borkow, et al.
Molecular Pharmacology|November 1, 1996
Differences in the inhibition of human immunodeficiency virus type 1 reverse transcriptase DNA polymerase activity by analogs of nevirapine and [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1", 2"-oxathiole-2",2"-dioxide] (TSAO)D Arion, R S Fletcher, G Borkow, et al.
Protein Expression and Purification|February 1, 1996
Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptaseR S Fletcher, G Holleschak, E Nagy, et al.
Journal of Human Virology|November 7, 1999
Increased CCR5 expression with decreased beta chemokine secretion in Ethiopians: relevance to AIDS in AfricaA Kalinkovich, Z Weisman, Q Leng, et al.
Science (New York, N.Y.)|March 1, 1996
Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptaseM A Wainberg, W C Drosopoulos, H Salomon, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Biochemistry|June 4, 1998
Physicochemical and biochemical properties of 2',5'-linked RNA and 2',5'-RNA:3',5'-RNA "hybrid" duplexesM Wasner, D Arion, G Borkow, et al.
Molecular Pharmacology|November 1, 1996
Differences in the inhibition of human immunodeficiency virus type 1 reverse transcriptase DNA polymerase activity by analogs of nevirapine and [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1", 2"-oxathiole-2",2"-dioxide] (TSAO)D Arion, R S Fletcher, G Borkow, et al.
Protein Expression and Purification|February 1, 1996
Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptaseR S Fletcher, G Holleschak, E Nagy, et al.
Journal of Human Virology|November 7, 1999
Increased CCR5 expression with decreased beta chemokine secretion in Ethiopians: relevance to AIDS in AfricaA Kalinkovich, Z Weisman, Q Leng, et al.
Science (New York, N.Y.)|March 1, 1996
Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptaseM A Wainberg, W C Drosopoulos, H Salomon, et al.
Pageof 5